Iliana Michailidou

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

From Dish to Trial: Building Translational Models of ALS.

From Dish to Trial: Building Translational Models of ALS.

Journal: Cells

Published: December 15, 2025

The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?

The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?

Journal: Frontiers in immunology

Published: November 11, 2024

Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors.

Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors.

Journal: Biomedicines

Published: April 29, 2024

Systemic LPS Administration Stimulates the Activation of Non-Neuronal Cells in an Experimental Model of Spinal Muscular Atrophy.

Systemic LPS Administration Stimulates the Activation of Non-Neuronal Cells in an Experimental Model of Spinal Muscular Atrophy.

Journal: Cells

Published: February 29, 2024

The Time Trajectory of Choroid Plexus Enlargement in Multiple Sclerosis.

The Time Trajectory of Choroid Plexus Enlargement in Multiple Sclerosis.

Journal: Healthcare (Basel, Switzerland)

Published: February 27, 2024

PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells.

PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells.

Journal: Brain : a journal of neurology

Published: December 06, 2023

Editorial: Complement in nervous system disease.

Editorial: Complement in nervous system disease.

Journal: Frontiers in cellular neuroscience

Published: July 27, 2023

Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Journal: Frontiers in cellular neuroscience

Published: July 27, 2023

Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Journal: Frontiers in cellular neuroscience

Published: April 13, 2023

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction.

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction.

Journal: Frontiers in neurology

Published: November 21, 2022

Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury.

Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: September 14, 2022

The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22.

The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22.

Journal: Current research in neurobiology

Published: March 18, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026